NucliThera AS is an unlisted, private company with two classes of shares where the founders control the A-shares with voting rights and 30+ investors hold B-shares without voting rights.

NucliThera AS is committed to provide all shareholders and potential investors with relevant financial information in a consistent and transparent manner.

IR Contact

For investor related matter please contact Ludvik Sandnes, CEO
+47 907 43 017 ludvik.sandnes@nuclithera.com